Professor Thomas Dörner, MD

Professor Thomas Dörner, MD

Charité University Hospitals Berlin,

Thomas Dörner is a board certified Rheumatologist and Professor of Rheumatology and Hemostaseology at Charité University Hospitals, Berlin, and group leader at the German Research Center of Rheumatology, Berlin (DRFZ). He qualified in medicine in 1990 at Charité University Hospitals, Berlin, and received his board certification in internal medicine in 1995 before undertaking a postdoctoral fellowship at the University of Texas, Southwestern Medical Center at Dallas, where he researched delineating molecular aspects of B-cell receptor gene usage in autoimmune diseases.

Professor Dorner has received a number of international and national awards, including the Senior Scholar Award of the American College of Rheumatology, the H Schultze Award of the German League Against Rheumatism, the Randy Fischer Prize for Excellence in flow cytometry and the Schoen Award of the German Society of Rheumatology.

Professor Dörner has served as a member of Editorial Boards of leading journals in rheumatology and immunology, including Arthritis & Rheumatism, Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Global Arthritis Research Network (GARN), Current Reviews in Rheumatology, Brazilian Journal of Rheumatology, European Journal of Immunology, Lupus Science & Medicine and Rheumatology Reviews.

Professor Dorner has led various clinical trials on rheumatic diseases, including systemic lupus erythematosus, Sjogren’s syndrome, rheumatoid arthritis and seronegative spondyloarthropathies. His research interests focus on the characterisation of disturbances of humoral autoimmunity and abnormalities of B cell subsets in the blood versus tissue (lupus, neonatal lupus syndromes, Sjogren’s syndrome), exploring innovative therapeutic approaches with particular focus on B-cell directed therapy as well as improving diagnostic tools in autoimmune diseases.


Grants/Research Support: Janssen/J&J; Roche/Chugai; Sanofi; UCB
Meeting Honorarium/Expenses: Eli Lilly; Roche; UCB
Speakers’ Bureau: Eli lilly; Roche; UCB

Professor Dörner is a member of the Lupus Academy Steering Committee and has been involved in the planning and development of the 5th Annual Meeting programme and materials.

Lupus Academy Foundation
Maasdijk 409
4264 AS Veen
The Netherlands
Tel: +31 (0) 416 693 925